Does Pioglitazone Have the Same Effects on NASH in Patients With vs Without Diabetes?
Patients with prediabetes and nonalcoholic steatohepatitis (NASH) benefit nearly as much from pioglitazone therapy as those with type-2 diabetes, researchers report in the April issue of Clinical
agacomm
April 3, 2018
No Comments
